Ginkgo Bioworks Holdings, Inc. (DNA)
NYSE: DNA · Real-Time Price · USD
11.58
+0.75 (6.93%)
At close: Jan 21, 2025, 4:00 PM
11.63
+0.05 (0.43%)
After-hours: Jan 21, 2025, 7:13 PM EST
Ginkgo Bioworks Holdings Employees
Ginkgo Bioworks Holdings had 1,218 employees as of December 31, 2023. The number of employees decreased by 74 or -5.73% compared to the previous year.
Employees
1,218
Change (1Y)
-74
Growth (1Y)
-5.73%
Revenue / Employee
$178,942
Profits / Employee
-$534,638
Market Cap
614.69M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1,218 | -74 | -5.73% |
Dec 31, 2022 | 1,292 | 651 | 101.56% |
Dec 31, 2021 | 641 | 146 | 29.49% |
Dec 31, 2020 | 495 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
DNA News
- 16 hours ago - SaponiQx, Probius, and Ginkgo Bioworks Unite to Revolutionize Vaccine Adjuvant Development - Business Wire
- 8 days ago - Ginkgo Bioworks Partners with Universal Cells, an Astellas Company, to Advance Next-Generation iPSC-Derived Cell Therapies for Solid Tumors - PRNewsWire
- 12 days ago - Rapid Rise of Synthetic Biology Fuels Enzymatic DNA Synthesis Boom Across Biopharma and Genomics - GlobeNewsWire
- 12 days ago - Ginkgo Bioworks Announces Participation in the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 5 weeks ago - Ginkgo Bioworks Awarded $9.4 Million in Partnership with Carnegie Mellon University to Develop Implantable Cell-Based Bioelectronic Devices for Disease Treatment Under ARPA-H's REACT Program - PRNewsWire
- 2 months ago - Ginkgo Bioworks: Unproven Transition But 2025 Is Looking Better - Seeking Alpha
- 2 months ago - Ginkgo Bioworks: Not Enough Progress - Seeking Alpha
- 2 months ago - Ginkgo Bioworks Holdings, Inc. (DNA) Q3 2024 Earnings Call Transcript - Seeking Alpha